Next generation process development and quality control in protein lyophilization using mechanistic and AI approaches

Active Definitive Contract Awarded Last action

Contract number
75F40126C00098
Awardee
Awarding agency
Obligated
$733,525

Award facts

Opportunity
  • 11212025 Solicitation number
Contract value 100% obligated
$733,525.00 Current and potential, with all options
Completion date 6% complete
Current and potential, with all options
Contracting staff
NAICS code
541714 Research and Development in Biotechnology (except Nanobiotechnology)
PSC
AN11 Health R&D Services; Health Care Services; Basic Research
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Slovenia
Legislative mandates

Award details come from SAM.gov/FPDS.

About this award

The Food and Drug Administration awarded a $733,525 firm fixed-price definitive contract to Research Center Pharmaceutical Engineering GMBH for next generation process development and quality control in protein lyophilization using mechanistic and AI approaches on September 11, 2026.

Work is performed in Slovenia. The contract runs through September 10, 2028. No set-aside was applied.

Quick answers

Who was awarded contract 75F40126C00098?

75F40126C00098 was awarded to Research Center Pharmaceutical Engineering GMBH by Food and Drug Administration (Department of Health and Human Services) on September 11, 2026.

How much is contract 75F40126C00098 worth?

The government has obligated $733,525 on 75F40126C00098.

Was contract 75F40126C00098 competed?

The extent of competition for 75F40126C00098 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award